VXRT EBITDA | Vaxart, Inc.

Vaxart, Inc. (VXRT) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$13.17M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $5.17M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$7.81M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$14.60M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-26 to 2017-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$13.17M	(m)	(m)	(m)	$35.00K*	$2.78M*	(m)	$33.75M	(m)	$29.00K
2026-03-31	Reported	(m)	$5.17M	(m)	(m)	(m)	$448.00K	-$2.05M	(m)	$29.41M	(m)	$29.00K
2025-09-30	Reported	(m)	-$7.81M	(m)	(m)	(m)	$117.00K*	$2.60M*	(m)	$75.95M	(m)	$17.00K
2025-06-30	Reported	(m)	-$14.60M	(m)	(m)	(m)	-$103.00K*	-$15.95M*	(m)	$49.73M	(m)	$20.00K
2025-03-31	Reported	(m)	-$14.94M	(m)	(m)	(m)	$130.00K	-$9.60M	(m)	$30.74M	(m)	$95.00K
2024-09-30	Reported	(m)	-$14.47M	(m)	(m)	(m)	$9.00K*	-$4.20M*	(m)	$15.07M	(m)	$18.00K
2024-06-30	Reported	(m)	-$16.26M	(m)	(m)	(m)	$370.00K*	-$12.03M*	(m)	$17.48M	(m)	$21.00K
2024-03-31	Reported	(m)	-$24.07M	(m)	(m)	(m)	$131.00K	-$21.19M	(m)	$19.01M	(m)	$45.00K
2023-09-30	Reported	(m)	-$17.82M	(m)	(m)	(m)	$282.00K*	-$15.00M*	(m)	$15.00M	(m)	$39.00K
2023-06-30	Reported	(m)	-$23.05M	(m)	(m)	(m)	$454.00K*	-$17.47M*	(m)	$18.81M	(m)	$19.00K
2023-03-31	Reported	(m)	-$25.57M	(m)	(m)	(m)	$1.24M	-$24.46M	(m)	$19.62M	(m)	$29.00K
2022-09-30	Reported	(m)	-$29.43M	(m)	(m)	(m)	$2.03M*	-$14.62M*	(m)	$22.47M	(m)	$16.00K
2022-06-30	Reported	(m)	-$29.25M	(m)	(m)	(m)	$2.33M*	-$25.90M*	(m)	$19.93M	(m)	$15.00K
2022-03-31	Reported	(m)	-$24.78M	(m)	(m)	(m)	$1.35M	-$25.11M	(m)	$18.20M	(m)	$20.00K
2021-09-30	Reported	(m)	-$17.25M	(m)	(m)	(m)	$1.32M*	-$14.27M*	(m)	$12.41M	(m)	$21.00K
2021-06-30	Reported	(m)	-$15.78M	(m)	(m)	(m)	$2.20M*	-$13.16M*	(m)	$10.74M	(m)	$30.00K
2021-03-31	Reported	(m)	-$15.51M	(m)	(m)	(m)	$615.00K	-$16.59M	(m)	$10.07M	(m)	$38.00K
2020-09-30	Reported	(m)	-$7.59M	(m)	(m)	(m)	$308.00K*	-$9.26M*	(m)	$4.62M	(m)	$26.00K
2020-06-30	Reported	(m)	-$8.53M	(m)	(m)	(m)	$9.00K*	-$521.00K*	(m)	$5.11M	(m)	$26.00K
2020-03-31	Reported	(m)	-$694.00K	(m)	(m)	(m)	$4.00K	-$3.21M	(m)	$1.54M	(m)	$153.00K
2019-09-30	Reported	(m)	-$4.71M	(m)	(m)	(m)	$127.00K*	-$4.33M*	(m)	$3.71M	(m)	$31.00K
2019-06-30	Reported	(m)	-$5.00M	(m)	(m)	(m)	$159.00K*	-$317.00K*	(m)	$3.71M	(m)	$13.00K
2019-03-31	Reported	(m)	-$448.00K	(m)	(m)	(m)	$552.00K	-$4.65M	(m)	$3.83M	(m)	$250.00K
2018-09-30	Reported	(m)	-$5.88M	(m)	(m)	(m)	$173.00K*	-$5.36M*	(m)	$4.38M	(m)	$0.00*
2018-06-30	Reported	(m)	-$7.78M	(m)	(m)	(m)	$199.00K*	$7.10M*	(m)	$5.01M	(m)	$1.00K
2018-03-31	Reported	(m)	-$3.92M	(m)	(m)	(m)	$140.00K	-$10.59M	(m)	$3.41M	$2.01M	$28.00K
2017-12-31	Reported	(m)	-$2.90M	(m)	(m)	(m)	(m)	-$4.70M*	(m)	$2.50M	(m)	$100.00K
2017-09-30	Reported	(m)	-$1.96M	(m)	(m)	(m)	-$19.00K*	-$4.50M	(m)	$2.25M	(m)	(m)
2017-06-30	Reported	(m)	-$3.12M	(m)	(m)	(m)	$16.00K*	-$1.75M*	(m)	$4.32M	(m)	(m)
2017-03-31	Reported	(m)	-$2.25M	(m)	(m)	(m)	$79.00K	-$4.28M	(m)	$3.88M	$678.00K	$200.00K
2016-12-31	Reported	(m)	-$8.60M	(m)	(m)	(m)	(m)	-$9.00M*	(m)	$10.20M	(m)	$100.00K
2016-09-30	Reported	(m)	-$9.60M	(m)	(m)	(m)	(m)	-$10.70M	(m)	$7.60M	(m)	(m)
2016-03-31	Reported	(m)	-$5.20M	(m)	(m)	(m)	(m)	-$7.00M*	(m)	$8.50M	(m)	(m)
2015-12-31	Reported	(m)	-$6.50M	(m)	(m)	(m)	(m)	-$9.10M*	(m)	$6.30M	(m)	(m)
2015-09-30	Reported	(m)	-$6.70M	(m)	(m)	(m)	(m)	$900.00K	(m)	$5.50M	(m)	(m)
2015-06-30	Reported	-$20M	(m)	(m)	(m)	-487.80%	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Reported	$1.40M*	$1.10M	$300.00K*	(m)	(m)	(m)	$800.00K*	(m)	$4.80M	(m)	(m)
2014-12-31	Reported	$6.80M*	$6.40M	$400.00K*	(m)	(m)	(m)	$1.00M*	(m)	$4.80M	(m)	(m)
2014-09-30	Reported	-$6.6M	(m)	(m)	(m)	-942.86%	(m)	-$11.60M	(m)	$4.90M	(m)	(m)
2014-06-30	Reported	-$9.5M	(m)	(m)	(m)	-113.10%	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Reported	$3.60M*	$3.20M	$400.00K*	(m)	(m)	$100.00K*	$700.00K*	(m)	$4.10M	(m)	$0.00*
2013-12-31	Reported	$400.00K*	-$100.00K	$500.00K*	(m)	(m)	$0.00*	-$8.40M*	(m)	$4.20M	(m)	$0.00*
2013-09-30	Reported	-$3.6M	(m)	(m)	(m)	-29.27%	$100.00K	-$6.20M	(m)	$3.00M	(m)	-$100.00K
2013-06-30	Reported	-$5.8M	(m)	(m)	(m)	-62.37%	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Reported	$900.00K*	$0.00	$900.00K*	(m)	(m)	$100.00K*	-$3.60M*	(m)	$4.50M	(m)	-$12.00K
2012-12-31	Reported	-$6.90M*	-$7.80M	$900.00K*	(m)	(m)	$200.00K*	-$7.60M*	(m)	$4.60M	(m)	-$6.00K
2012-09-30	Reported	-$7.2M	(m)	(m)	(m)	-480.00%	$200.00K	-$5.20M	(m)	$4.60M	(m)	-$100.00K
2012-06-30	Reported	-$5.91M	(m)	(m)	(m)	-83.51%	(m)	-$2.23M*	(m)	$1.33M	(m)	-$817.00K*
2012-03-31	Reported	-$2.61M	(m)	(m)	(m)	-36.85%	$203.00K*	-$1.51M	(m)	$5.71M	(m)	$146.00K
2011-12-31	Reported	-$8.31M	(m)	(m)	(m)	-396.99%	(m)	(m)	(m)	$5.73M	(m)	-$520.00K
2011-09-24	Reported	-$4.92M*	-$4.94M	$20.00K*	(m)	(m)	$0.00*	-$5.43M*	(m)	$4.39M	(m)	-$2.02M
2011-09-24	Reported	(m)	-$4.94M	(m)	(m)	(m)	(m)	(m)	(m)	$4.39M	(m)	-$2.02M
2011-06-25	Reported	-$4.64M*	-$4.69M	$45.00K*	(m)	(m)	(m)	-$428.00K*	(m)	$6.46M	(m)	(m)
2011-03-26	Reported	$1.94M	(m)	(m)	(m)	21.11%	(m)	-$8.60M	(m)	$5.33M	(m)	(m)
2010-12-25	Reported	-$6.31M	(m)	(m)	(m)	-154.53%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-25	Reported	$3.36M*	$3.28M	$82.00K*	(m)	(m)	$1.00K*	$1.06M*	(m)	$6.80M	(m)	-$1.76M
2010-06-26	Reported	(m)	-$3.49M	(m)	(m)	(m)	(m)	(m)	(m)	$6.53M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$18.07M	(m)	(m)	(m)	$145.00K	$7.71M	(m)	$201.58M	(m)	$476.00K
2024-12-31	Reported	(m)	-$66.29M	(m)	(m)	(m)	$554.00K	-$44.76M	(m)	$74.21M	(m)	$260.00K
2023-12-31	Reported	(m)	-$83.35M	(m)	(m)	(m)	$1.87M	-$70.45M	(m)	$68.14M	(m)	$261.00K
2022-12-31	Reported	(m)	-$114.59M	(m)	(m)	(m)	$9.60M	-$94.78M	(m)	$81.05M	(m)	$67.00K
2021-12-31	Reported	(m)	-$72.75M	(m)	(m)	(m)	$5.16M	-$59.83M	(m)	$48.75M	(m)	$107.00K
2020-12-31	Reported	(m)	-$30.17M	(m)	(m)	(m)	$1.22M	-$23.75M	(m)	$19.86M	(m)	$238.00K
2019-12-31	Reported	(m)	-$15.79M	(m)	(m)	(m)	$850.00K	-$13.09M	(m)	$14.54M	(m)	$490.00K
2018-12-31	Reported	(m)	-$21.76M	(m)	(m)	(m)	$707.00K	-$14.55M	(m)	$17.27M	(m)	$109.00K
2018-09-30	Rolling	(m)	-$20.47M*	(m)	(m)	(m)	(m)	-$13.55M*	(m)	$15.30M*	(m)	$129.00K*
2018-06-30	Rolling	(m)	-$16.55M*	(m)	(m)	(m)	(m)	-$12.69M*	(m)	$13.17M*	(m)	(m)
2018-03-31	Rolling	(m)	-$11.89M*	(m)	(m)	(m)	(m)	-$21.54M*	(m)	$12.48M*	(m)	(m)
2017-12-31	Reported	(m)	-$10.02M	(m)	(m)	(m)	$117.00K	-$10.04M	(m)	$12.36M	(m)	(m)
2017-12-31	Rolling	(m)	-$10.23M*	(m)	(m)	(m)	(m)	-$15.22M*	(m)	$12.95M*	(m)	(m)
2017-09-30	Rolling	(m)	-$15.93M*	(m)	(m)	(m)	(m)	-$19.52M*	(m)	$20.65M*	(m)	(m)
2017-06-30	Reported	-$27.4M	(m)	(m)	(m)	-307.87%	(m)	(m)	(m)	$28.30M	(m)	$300.00K
2017-06-30	Rolling	(m)	-$23.57M*	(m)	(m)	(m)	(m)	-$25.72M*	(m)	$26.00M*	(m)	(m)
2016-06-30	Reported	-$25.1M	(m)	(m)	(m)	-269.89%	$200.00K	(m)	(m)	$26.30M	(m)	(m)
2015-06-30	Reported	-$18.4M	(m)	(m)	(m)	-74.80%	$100.00K	-$9.60M	(m)	$19.80M	(m)	-$100.00K
2014-06-30	Reported	-$9.1M	(m)	(m)	(m)	-13.25%	$100.00K	-$3.30M	(m)	$17.50M	(m)	-$300.00K
2013-06-30	Reported	-$19.1M	(m)	(m)	(m)	-56.85%	$1.00M	-$13.90M	(m)	$19.90M	(m)	$100.00K
2013-03-31	Rolling	-$16.06M*	-$18.48M*	$2.42M*	(m)	(m)	(m)	-$18.63M*	(m)	$15.03M*	(m)	-$935.00K*
2012-12-31	Rolling	-$19.57M*	-$21.11M*	$1.53M*	(m)	(m)	(m)	-$16.54M*	(m)	$16.24M*	(m)	-$777.00K*
2012-09-30	Rolling	(m)	-$21.72M*	(m)	(m)	(m)	(m)	(m)	(m)	$17.37M*	(m)	-$1.29M*
2012-06-30	Reported	-$19.8M	(m)	(m)	(m)	-97.06%	$1.30M	-$15.90M	(m)	$24.10M	(m)	-$500.00K
2011-12-31	Reported	-$9.53M	(m)	(m)	(m)	-64.19%	$1.00K	-$15.17M	(m)	$17.77M	(m)	-$2.02M
2011-06-30	Reported	-$27.5M	(m)	(m)	(m)	-220.00%	$700.00K	-$33.70M	(m)	$33.50M	(m)	-$800.00K
2010-12-25	Reported	-$822,000.00	(m)	(m)	(m)	-2.35%	$154.00K	$39.93M	(m)	$26.08M	(m)	-$1.76M
2009-12-26	Reported	-$17.47M	(m)	(m)	(m)	-166.59%	$4.00K	$6.22M	(m)	$16.49M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kalaris Therapeutics, Inc. (KLRS)	United States	$0.073B	-2.19
Atara Biotherapeutics, Inc. (ATRA)	United States	$0.086B	-6.48
Pelthos Therapeutics Inc. (PTHS)	United States	$0.086B	-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)	United States	$0.070B	-68.02
COGNITION THERAPEUTICS INC (CGTX)	United States	$0.090B	-6.52
BioStem Technologies, Inc. (BSEM)	United States	$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)	United States	$0.065B
MiNK Therapeutics, Inc. (INKT)	United States	$0.063B	-5.37
Cardiff Oncology, Inc. (CRDF)	United States	$0.101B	-2.22
EXOZYMES INC. (EXOZ)	United States	$0.058B